menu
    • menu

    Company profile for Vericel Corporation

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects ...
    Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vericel CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    64 Sidney Street, Cambridge, MA 02139
    Telephone
    Telephone
    (617) 588-5555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vcel.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vericel-corporation
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VericelCorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vericel To Release 2025 Financial Results On Feb 26, 2026
    Vericel To Release 2025 Financial Results On Feb 26, 2026

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237182/34447/en/Vericel-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26-2026.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Vericel Unveils 2025 Financials And Business Updates
    Vericel Unveils 2025 Financials And Business Updates

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217833/34447/en/Vericel-Announces-Preliminary-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Vericel To Present At 44th J.P. Morgan Healthcare Conference
    Vericel To Present At 44th J.P. Morgan Healthcare Conference

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213631/34447/en/Vericel-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-on-Wednesday-January-14-2026.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Vericel To Present At Stephens Investment Conference On Nov 20
    Vericel To Present At Stephens Investment Conference On Nov 20

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188310/34447/en/Vericel-to-Present-at-the-Stephens-Annual-Investment-Conference-on-Thursday-November-20-2025.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Vericel To Release Q3 2025 Financial Results On Nov 6, 2025
    Vericel To Release Q3 2025 Financial Results On Nov 6, 2025

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172034/34447/en/Vericel-to-Report-Third-Quarter-2025-Financial-Results-on-November-6-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Vericel to Present at Wells Fargo Healthcare Conference
    Vericel to Present at Wells Fargo Healthcare Conference

    28 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/28/3140782/34447/en/Vericel-to-Present-at-the-Wells-Fargo-Healthcare-Conference-on-Thursday-September-4-2025.html

    GLOBENEWSWIRE
    28 Aug 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search